OPKO Health Cash on Hand 2012-2026 | OPK

OPKO Health cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
OPKO Health Annual Cash on Hand
(Millions of US $)
2025 $369
2024 $432
2023 $96
2022 $153
2021 $135
2020 $72
2019 $85
2018 $96
2017 $91
2016 $169
2015 $194
2014 $97
2013 $186
2012 $27
2011 $72
OPKO Health Quarterly Cash on Hand
(Millions of US $)
2026-06-30 $301
2026-03-31 $342
2025-12-31 $369
2025-09-30 $415
2025-06-30 $272
2025-03-31 $436
2024-12-31 $432
2024-09-30 $406
2024-06-30 $41
2024-03-31 $76
2023-12-31 $96
2023-09-30 $139
2023-06-30 $108
2023-03-31 $111
2022-12-31 $153
2022-09-30 $181
2022-06-30 $210
2022-03-31 $102
2021-12-31 $135
2021-09-30 $149
2021-06-30 $66
2021-03-31 $90
2020-12-31 $72
2020-09-30 $36
2020-06-30 $22
2020-03-31 $35
2019-12-31 $85
2019-09-30 $65
2019-06-30 $111
2019-03-31 $207
2018-12-31 $96
2018-09-30 $44
2018-06-30 $80
2018-03-31 $100
2017-12-31 $91
2017-09-30 $100
2017-06-30 $131
2017-03-31 $131
2016-12-31 $169
2016-09-30 $145
2016-06-30 $172
2016-03-31 $175
2015-12-31 $194
2015-09-30 $212
2015-06-30 $221
2015-03-31 $348
2014-12-31 $97
2014-09-30 $118
2014-06-30 $134
2014-03-31 $156
2013-12-31 $186
2013-09-30 $181
2013-06-30 $169
2013-03-31 $182
2012-12-31 $27
2012-09-30 $42
2012-06-30 $55
2012-03-31 $62
2011-12-31 $72
2011-09-30 $87
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.172B $0.607B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $237.152B 26.92
Intuitive Surgical (ISRG) United States $133.242B 45.17
Edwards Lifesciences (EW) United States $49.369B 30.51
IQVIA Holdings (IQV) United States $44.388B 23.74
Waters (WAT) United States $40.978B 30.49
IDEXX Laboratories (IDXX) United States $40.236B 35.92
Alcon (ALC) Switzerland $33.515B 20.78
DexCom (DXCM) United States $32.623B 33.90
Mettler-Toledo (MTD) United States $26.657B 29.64
STERIS (STE) Ireland $20.502B 20.18
Hologic (HOLX) United States $16.752B 17.53
SONOVA HOLDING (SONVY) Switzerland $16.610B 0.00
Coloplast (CLPBY) Denmark $14.694B 17.62
Penumbra (PEN) United States $12.543B 82.71
Fresenius Medical Care AG KGaA (FMS) Germany $12.332B 8.63
Glaukos (GKOS) United States $10.126B 0.00
Globus Medical (GMED) United States $10.028B 15.18
Masimo (MASI) United States $9.578B 30.69
SARTORIUS (SSSGY) Germany $7.521B 43.67
Sysmex ADR (SSMXY) Japan $7.442B 28.15
Teleflex (TFX) United States $5.467B 14.74
LivaNova (LIVN) United Kingdom $4.378B 22.14
Integer Holdings (ITGR) United States $4.291B 19.88
Pulse Biosciences (PLSE) United States $3.820B 0.00
Veracyte (VCYT) United States $3.227B 26.41
TransMedics (TMDX) United States $3.044B 44.72
AxoGen (AXGN) United States $2.418B 0.00
UFP Technologies (UFPT) United States $2.134B 26.93
Elekta AB (EKTAY) Sweden $1.948B 18.22
Nihon Kohden (NHNKY) Japan $1.688B 15.46
Alphatec Holdings (ATEC) United States $1.646B 0.00
Alpha Tau Medical (DRTS) Israel $1.343B 0.00
Artivion (AORT) United States $1.237B 47.00
Integra LifeSciences Holdings (IART) United States $1.220B 6.35
AVANOS MEDICAL, INC (AVNS) United States $1.171B 27.77
Tandem Diabetes Care (TNDM) United States $1.133B 0.00
PROCEPT BioRobotics (PRCT) United States $1.105B 0.00
IRadimed (IRMD) United States $1.054B 46.04
Beta Bionics (BBNX) United States $0.865B 0.00
SiBone (SIBN) United States $0.823B 0.00
Anteris Technologies Global (AVR) Australia $0.813B 0.00
Mesa Laboratories (MLAB) United States $0.712B 17.14
AngioDynamics (ANGO) United States $0.648B 0.00
OrthoPediatrics (KIDS) United States $0.607B 0.00
Delcath Systems (DCTH) United States $0.561B 1617.00
Tactile Systems Technology (TCMD) United States $0.510B 20.84
NeuroPace (NPCE) United States $0.489B 0.00
Sight Sciences (SGHT) United States $0.447B 0.00
Pacific Biosciences Of California (PACB) United States $0.417B 0.00
908 Devices (MASS) United States $0.412B 0.00
ClearPoint Neuro (CLPT) United States $0.401B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.370B 0.00
Mobia Medical (MOBI) United States $0.359B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Treace Medical Concepts (TMCI) United States $0.298B 0.00
Spectral Diagnostics (EDTXF) Canada $0.266B 0.00
RxSight (RXST) United States $0.234B 0.00
Neuronetics (STIM) United States $0.213B 0.00
Lucid Diagnostics (LUCD) United States $0.161B 0.00
FocalTherics (FOCL) France $0.153B 0.00
Inogen (INGN) United States $0.138B 0.00
EDAP TMS S.A (EDAP) France $0.124B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.094B 0.00
Hyperfine (HYPR) United States $0.085B 0.00
Zomedica (ZOMDF) United States $0.082B 0.00
CVRx (CVRX) United States $0.080B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.070B 23.00
DarioHealth (DRIO) United States $0.066B 0.00
Positron (POSC) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.058B 0.00
Envoy Medical (COCH) United States $0.055B 0.00
Nano-X Imaging (NNOX) Israel $0.054B 0.00
Vaso (VASO) United States $0.051B 29.09
Spectral AI (MDAI) United States $0.051B 0.00
Sensus Healthcare (SRTS) United States $0.051B 0.00
Precision Optics (POCI) United States $0.046B 0.00
Baird Medical Investment Holdings (BDMD) $0.045B 0.00
InspireMD (NSPR) United States $0.036B 0.00
QT Imaging Holdings (QTI) United States $0.035B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
PAVmed (PAVM) United States $0.031B 0.00
Accuray (ARAY) United States $0.028B 0.00
Adagio Medical Holdings (ADGM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
EnVVeno Medical (NVNO) United States $0.006B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
NexGel (NXGL) United States $0.003B 0.00
ENvue Medical (FEED) United States $0.001B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.000B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00